Lilly’s bamlanivimab prevents Covid-19 at nursing homes in BLAZE-2 trial
Eli Lilly and Company has announced results from the Phase III BLAZE-2 trial, which showed bamlanivimab (LY-CoV555) significantly lowered the…
Latest News
-
19 hours
-
20 hours
-
23 hours
-
23 hours
-
19 hours
-
20 hours
-
23 hours
-
23 hours
Moderna begins dosing in Covid-19 vaccine study in Japan
Moderna has dosed the first participant in the Phase I/II study of its Covid-19 vaccine candidate, (mRNA-1273 or TAK-919), in…
Latest News
View More
Synairgen concludes recruitment in Covid-19 inhaled drug study
UK-based company Synairgen has completed the recruitment of 120 subjects in its Phase II trial of an inhaled formulation of interferon-beta-1a (SNG001) for treating ‘at…
Cross-EU drug supply chain to be most affected post Brexit: Poll
The UK’s decision to opt out of the European Union (EU) has set numerous industries up for disruptions especially after the official exit in January…
Pharm-Olam to support Adalimumab COVID Therapeutic Trial
Global clinical research organisation (CRO) Pharm-Olam has been selected by the US Department of Defense (DOD) to lead and offer…
BioEclipse starts enrolment in Phase I refractory solid tumour trial
Clinical-stage biopharmaceutical company BioEclipse Therapeutics has initiated patient enrolment in a Phase I dose-escalation trial of CRX100 for treating refractory…
Bioclinica unveils ‘Image Redact AI’ solution for clinical trials
Clinical life science solutions provider Bioclinica has expanded its portfolio of specialty software solutions with the addition of ‘Image Redact…
Apnimed doses first patient in obstructive sleep apnea drug trial
Clinical-stage pharma company Apnimed has announced the dosing of the first patient in a Phase II clinical trial of its…
Latest Content
View More
ImmunityBio to begin Covid-19 vaccine candidate trial in South Africa
ImmunityBio is set to initiate a Phase I clinical trial of its novel subcutaneous Covid-19 vaccine candidate, hAd5 T-cell, in…
Genkyotex’s setanaxib shows favourable safety profile in Phase I trial
French biopharmaceutical firm Genkyotex has reported positive data from the Phase I trial of its lead product candidate, setanaxib (GKT831),…
Three Things To Know About ADaM Standards
When it comes to clinical trial submission, one of the most significant standards is the Analysis Data Model (ADaM), as…
Live Animal Imaging in Oncology Preclinical Drug Development
Small animal optical imaging provides oncology researchers with the ability to perform non-invasive longitudinal monitoring of disease progression, detection of…
GEMTESA (vibegron) for the Treatment of Overactive Bladder (OAB)
GEMTESA® (vibegron) is the first new oral medication indicated for the treatment of overactive bladder (OAB) with signs of urge…
OpenClinica Featured in ‘In Depth’ Educational TV Series
OpenClinica is pleased to announce that it will be included in public television series In Depth, exhibiting its clinical trials…